Cargando…

Mucin-Type O-Glycans: Barrier, Microbiota, and Immune Anchors in Inflammatory Bowel Disease

Inflammatory bowel disease (IBD), which affects about 7 million people globally, is a chronic inflammatory condition of the gastrointestinal tract caused by gut microbiota alterations, immune dysregulation, and genetic and environmental factors. The association of microbial and immune molecules with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yaqin, Wang, Lan, Ocansey, Dickson Kofi Wiredu, Wang, Bo, Wang, Li, Xu, Zhiwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598207/ https://www.ncbi.nlm.nih.gov/pubmed/34803391 http://dx.doi.org/10.2147/JIR.S327609

Ejemplares similares

Mesenchymal stem cell–gut microbiota interaction in the repair of inflammatory bowel disease: an enhanced therapeutic effect
por: Ocansey, Dickson Kofi Wiredu, et al.
Publicado: (2019)

Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy
por: Wang, Yifei, et al.
Publicado: (2022)

Role of ferroptosis in the pathogenesis and as a therapeutic target of inflammatory bowel disease (Review)
por: Ocansey, Dickson Kofi Wiredu, et al.
Publicado: (2023)

Cellular and molecular mediators of lymphangiogenesis in inflammatory bowel disease
por: Ocansey, Dickson Kofi Wiredu, et al.
Publicado: (2021)

Resveratrol alleviates DSS-induced IBD in mice by regulating the intestinal microbiota-macrophage-arginine metabolism axis
por: Xu, Xinwei, et al.
Publicado: (2023)

Role of glycolysis in inflammatory bowel disease and its associated colorectal cancer
por: Xia, Yuxuan, et al.
Publicado: (2023)

The gut metagenomics and metabolomics signature in patients with inflammatory bowel disease
por: Xu, Xinwei, et al.
Publicado: (2022)

Human umbilical cord mesenchymal stem cells derived exosome shuttling mir-129-5p attenuates inflammatory bowel disease by inhibiting ferroptosis
por: Wei, Zhiping, et al.
Publicado: (2023)

The role of mesenchymal stem cell-derived exosome in epigenetic modifications in inflammatory diseases
por: Zhao, Zihan, et al.
Publicado: (2023)

Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer
por: Zhou, Mengjiao, et al.
Publicado: (2022)

The Emerging Clinical Application of m6A RNA Modification in Inflammatory Bowel Disease and Its Associated Colorectal Cancer
por: Xu, Xinwei, et al.
Publicado: (2021)

The diagnostic and prognostic potential of gut bacteria in inflammatory bowel disease
por: Wiredu Ocansey, Dickson Kofi, et al.
Publicado: (2023)

The Achievements and Challenges of Mesenchymal Stem Cell-Based Therapy in Inflammatory Bowel Disease and Its Associated Colorectal Cancer
por: Ocansey, Dickson Kofi Wiredu, et al.
Publicado: (2020)

Regulatory Effect of Mesenchymal Stem Cells on T Cell Phenotypes in Autoimmune Diseases
por: Wei, Zhiping, et al.
Publicado: (2021)

hucMSC-Ex Alleviates IBD-Associated Intestinal Fibrosis by Inhibiting ERK Phosphorylation in Intestinal Fibroblasts
por: Wang, Yifei, et al.
Publicado: (2023)

The effect of students’ online learning experience on their satisfaction during the COVID-19 pandemic: The mediating role of preference
por: Li, Xinchao, et al.
Publicado: (2023)

Mucin-derived O-glycans supplemented to diet mitigate diverse microbiota perturbations
por: Pruss, K. M., et al.
Publicado: (2020)

Hypoxia-Regulated Tumor-Derived Exosomes and Tumor Progression: A Focus on Immune Evasion
por: Shao, Xuejun, et al.
Publicado: (2022)

Mucin O-glycan-microbiota axis orchestrates gut homeostasis in a diarrheal pig model
por: Xia, Bing, et al.
Publicado: (2022)

Emerging roles of mesenchymal stem cell-derived exosomes in gastrointestinal cancers
por: Wang, Naijian, et al.
Publicado: (2022)

The Effects of Mesenchymal Stem Cell on Colorectal Cancer
por: Yuan, Jintao, et al.
Publicado: (2021)

Glycosylation in Cervical Cancer: New Insights and Clinical Implications
por: Xu, Zhiwei, et al.
Publicado: (2021)

Role of mucin glycosylation in the gut microbiota-brain axis of core 3 O-glycan deficient mice
por: Coletto, Erika, et al.
Publicado: (2023)

Synthesis of mucin-type O-glycan probes as aminopropyl glycosides
por: Benito-Alifonso, David, et al.
Publicado: (2013)

Mucin O-glycans are natural inhibitors of Candida albicans pathogenicity
por: Takagi, Julie, et al.
Publicado: (2022)

A Sweet Warning: Mucin-Type O-Glycans in Cancer
por: Zhang, Yuhan, et al.
Publicado: (2022)

Synthesis of Mucin O‐Glycans Associated with Attenuation of Pathogen Virulence
por: Minzer, Giulietta, et al.
Publicado: (2022)

Structural and Quantitative Characterization of Mucin-Type O-Glycans and the Identification of O-Glycosylation Sites in Bovine Submaxillary Mucin
por: Kim, Jihye, et al.
Publicado: (2020)

Improved therapeutics of modified mesenchymal stem cells: an update
por: Ocansey, Dickson Kofi Wiredu, et al.
Publicado: (2020)

Inflammatory bowel diseases: Microbiota versus the barrier
por: Desai, Devendra
Publicado: (2015)

Decreased Gastric Gland Mucin-specific O-glycans Are Involved in the Progression of Ovarian Primary Mucinous Tumours
por: Ohya, Ayumi, et al.
Publicado: (2021)

Mucin O-glycans facilitate symbiosynthesis to maintain gut immune homeostasis
por: Yamada, Takahiro, et al.
Publicado: (2019)

Exosome‐mediated effects and applications in inflammatory bowel disease
por: Ocansey, Dickson K. W., et al.
Publicado: (2020)

HucMSC‐exosomes carrying miR‐326 inhibit neddylation to relieve inflammatory bowel disease in mice
por: Wang, Gaoying, et al.
Publicado: (2020)

The Double Face of Mucin-Type O-Glycans in Lectin-Mediated Infection and Immunity
por: Morozov, Vasily, et al.
Publicado: (2018)

Mucin glycan foraging in the human gut microbiome
por: Tailford, Louise E., et al.
Publicado: (2015)

Mucin Glycans: A Target for Cancer Therapy
por: Sun, Lingbo, et al.
Publicado: (2023)

Dual Roles of Gastric Gland Mucin-specific O-glycans in Prevention of Gastric Cancer
por: Nakayama, Jun
Publicado: (2014)

Sulfation of O-glycans on Mucin-type Proteins From Serous Ovarian Epithelial Tumors
por: Thomsson, Kristina A., et al.
Publicado: (2021)

Mucin O-glycans suppress quorum sensing pathways and genetic transformation in Streptococcus mutans
por: Werlang, Caroline A, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vsl8fklcppafco9ji7lr6tanhq